TickerFacts.

Vanda Pharmaceuticals Inc. (VNDA) — Operating Income

Annual figures by period end, from SEC filings.

2009-12-31: -$35.95M2010-12-31: $8.84M2011-12-31: -$10.71M2012-12-31: -$29.18M2013-12-31: -$21.20M2014-12-31: $20.06M2015-12-31: -$40.19M2016-12-31: -$18.57M2017-12-31: -$16.90M2018-12-31: $21.74M2019-12-31: $22.81M2020-12-31: $27.24M2021-12-31: $42.16M2022-12-31: $6.33M2023-12-31: -$13.95M2024-12-31: -$40.66M2025-12-31: -$151.17M-$151.17M
2009-12-31Operating Income (USD)2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-$151.17M—2026-02-12From 2025-01-01
2024-12-31-$40.66M—2026-02-12From 2024-01-01
2023-12-31-$13.95M-320.4%2026-02-12From 2023-01-01
2022-12-31$6.33M-85.0%2025-02-14From 2022-01-01
2021-12-31$42.16M+54.8%2024-02-08From 2021-01-01
2020-12-31$27.24M+19.4%2023-02-09From 2020-01-01
2019-12-31$22.81M+4.9%2022-02-24From 2019-01-01
2018-12-31$21.74M—2021-02-11From 2018-01-01
2017-12-31-$16.90M—2020-02-26From 2017-01-01
2016-12-31-$18.57M—2019-02-19From 2016-01-01
2015-12-31-$40.19M-300.3%2018-02-15From 2015-01-01
2014-12-31$20.06M—2017-02-17From 2014-01-01
2013-12-31-$21.20M—2016-02-12From 2013-01-01
2012-12-31-$29.18M—2015-03-13From 2012-01-01
2011-12-31-$10.71M-221.1%2014-02-25From 2011-01-01
2010-12-31$8.84M—2013-02-26From 2010-01-01
2009-12-31-$35.95M—2012-03-09From 2009-01-01